Download - Flow of study participants
Transcript
Subject Demographics and Baseline Lipid Characteristics*
John J.P. Kastelein, et al. Circulation 2006;114:1729-1735
Adverse Events Considered Related to Study Medication by Dosage
John J.P. Kastelein, et al. Circulation 2006;114:1729-1735
Dose-dependent effect of ISIS 301012 on apoB levels
John J.P. Kastelein, et al. Circulation 2006;114:1729-1735
John J.P. Kastelein, et al. Circulation 2006;114:1729-1735
Dose-dependent effect of ISIS 301012 on LDL cholesterol levels